Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
Abstract Background Patients newly diagnosed with lung adenocarcinoma B-3 with bone metastases (LABM) have poor survival rates after treatment with conventional therapies.To improve outcomes, we retrospectively investigated whether the application of a more comprehensive genetic test of tumor biopsies samples from LABM patients could provide the ba